Is it really about manipulation and lack of big deals? Maybe the technology is just plain unproven. Looking at all the past trials. Very very few data points with no trials with control arm. Good results could be purely placebo. Out of 100s of millions spent and decades time only a few data points. Maybe the drug only barely works but competition is fierce. Look at trials from companies like incy and vertex. The results are unbelievably definitive. Not so sure with ADXS.
Also, talk of adage manipulation or trying to stop manipulation are overblown. Adage probably barely remembers it bought adxs. It is 0.1 percent of their portfolio. A 100% loss and they would not even notice
Dan destroyed a lot of shareholder value coupled with a much higher cash burn coupled with us being late stage with solid but not ground braking data. Any talk about a valuation over 2b now is just wishful thinking. Sell the company for 1b and get it in the hands of real expert who can take it to market instead if risking another unqualified unethical lawyer looking to line his pockets instead of moving the company forward in a way that benefits the owners/investors.
Market Data 
Markets 
AI
